Access
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
Research Highlights
Nature Reviews Urology 6, 576 (1 November 2009) | doi:10.1038/nrurol.2009.184
Bladder cancer: Gemcitabine-based therapies offer no survival benefit
Abstract
B|[ouml]|hle, A. et al. Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomized, double-blind, placebo-controlled phase III multicentre trial. Eur.
To read this article in full you may need to log in, make a payment or gain access through a site license (see right).
